KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Elanco Animal Health (ELAN) Amortization - Intangibles (2017 - 2026)

Elanco Animal Health's Amortization - Intangibles history spans 9 years, with the latest figure at $139.0 million for Q4 2025.

  • On a quarterly basis, Amortization - Intangibles rose 6.92% to $139.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $543.0 million, a 3.04% increase, with the full-year FY2025 number at $543.0 million, up 3.04% from a year prior.
  • Amortization - Intangibles hit $139.0 million in Q4 2025 for Elanco Animal Health, down from $140.0 million in the prior quarter.
  • Over the last five years, Amortization - Intangibles for ELAN hit a ceiling of $147.0 million in Q1 2021 and a floor of $128.0 million in Q3 2022.
  • Historically, Amortization - Intangibles has averaged $135.1 million across 5 years, with a median of $135.0 million in 2023.
  • The widest YoY moves for Amortization - Intangibles: up 182.69% in 2021, down 14.72% in 2021.
  • Tracing ELAN's Amortization - Intangibles over 5 years: stood at $139.0 million in 2021, then decreased by 6.47% to $130.0 million in 2022, then increased by 6.15% to $138.0 million in 2023, then decreased by 5.8% to $130.0 million in 2024, then rose by 6.92% to $139.0 million in 2025.
  • Business Quant data shows Amortization - Intangibles for ELAN at $139.0 million in Q4 2025, $140.0 million in Q3 2025, and $136.0 million in Q2 2025.